Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00912795
Other study ID # ISK-NIH-FIC7918
Secondary ID 5R01TW007918
Status Completed
Phase Phase 1
First received May 19, 2009
Last updated January 31, 2012
Start date January 2009
Est. completion date September 2011

Study information

Verified date January 2012
Source Center for Innovative Public Health Research
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review BoardTurkey: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study is to develop and test a text messaging-based smoking cessation program for adults who are currently smoking and want to quit, living in Turkey.


Description:

Smoking has long been recognized as a significant public health concern associated with great morbidity and mortality. Although smoking rates have decreased in high income countries, these trends have not been noted for tow and middle income countries. This is especially true in Turkey, which was ranked 6th in the world in smoking consumption. Between 51-63% of Turkish men and 24-26% of Turkish women 15 years of age and older are smokers. With lung cancer the leading cancer-related cause of death for both men and women, effective and accessible smoking cessation interventions are needed. Cell phone technology represents a unique opportunity to deliver evidenced-based smoking cessation behavioral treatments through a delivery mechanism already widely adopted by adults. An estimated 35 million Turks were using cell phones, making them 1.8 times more common than land lines. Cell phone interventions are a unique delivery method because of their 'always on' capability. The rapid uptake of cell phones allows us to potentially reach those who might otherwise not utilize smoking cessation services.

We propose to design and evaluate an evidenced-based smoking intervention that takes advantage of technologies adopted by adult smokers in Turkey. SMS (Smoking Management System) Turkey will have both wide reach and high impact.

To do so, we bring together a multi-national team of smoking and technology health experts dedicated to building the capacity of smoking cessation research expertise in Turkey to reduce the public health burden associated with smoking in Turkey.


Recruitment information / eligibility

Status Completed
Enrollment 151
Est. completion date September 2011
Est. primary completion date September 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older

- Currently smoking every day

- Owning a TXT-capable cell phone

- Sent or received TXT messages at least once in the past year

- Living in Ankara (to ease technology support if necessary)

- Agreement to set quit day in 15 days from enrollment date

- Agreement to verification of smoking cessation using a carbon monoxide breath monitor

Exclusion Criteria:

• No chronic disease.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Behavioral:
SMS Turkey
6-week smoking cessation program delivered via text messaging

Locations

Country Name City State
Turkey Hacettepe University Ankara

Sponsors (2)

Lead Sponsor Collaborator
Center for Innovative Public Health Research Hacettepe University

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Ybarra ML, Bagci Bosi AT, Bilir N, Holtrop JS, Korchmaros J, Emri S. Interest in technology-based and traditional smoking cessation programs among adult smokers in Ankara, Turkey. Tob Induc Dis. 2011 Aug 1;9:10. doi: 10.1186/1617-9625-9-10. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary 12-week continuous abstinence self-reported continuous abstinence since quit day (<=5 cigarettes), verified with carbon monoxide reading (<=8ppm) 12-weeks post-quit day No
See also
  Status Clinical Trial Phase
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02649556 - A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 N/A
Completed NCT03901066 - Smoking Dependence and Periodontitis
Recruiting NCT05846841 - Personalized Tobacco Treatment in Primary Care (MOTIVATE) N/A
Completed NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Completed NCT03305978 - Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan. N/A
Completed NCT00000437 - Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Phase 4
Completed NCT06105424 - BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability N/A
Active, not recruiting NCT02752022 - Monitoring the Transition From Smoking to E-cigarettes
Completed NCT02901171 - The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation N/A
Completed NCT03206619 - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed NCT02912000 - TEACH: Technology Evaluation to Address Child Health N/A
Completed NCT04340830 - The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants N/A
Completed NCT02949648 - Electronic Cigarette Use and Quitting in Youth N/A
Completed NCT02945371 - Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life N/A
Completed NCT02246114 - Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women N/A
Completed NCT02008292 - Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors N/A
Completed NCT03448900 - Intervention Study for Smoking Cessation in Spanish College Students N/A
Completed NCT01898507 - Nicotine Metabolism and Low Nicotine Cigarettes N/A